Clinical trial
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
NCT00030303 · UConn Health, Other · Completed
Key facts
| NCT number | NCT00030303 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia |
| Official title | A Feasibility And Toxicity Study Of Vaccination With HSP70 For The Treatment Of Chronic Myelogenous Leukemia In Chronic Phase |
| Lead sponsor | UConn Health, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological |
| Interventions | recombinant 70-kD heat-shock protein |
| Enrollment | 20 |
| Start date | Jan 1, 2001 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: